Trigyn Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

30.79

30.79

30.79

30.79

30.79

Share application money

-

-

0.17

0.17

0.17

Preference share capital

-

-

-

-

-

Reserves & surplus

157.58

158.41

154.76

154.22

151.42

Loan funds

Secured loans

0.26

2.06

4.92

8.47

5.97

Unsecured loans

-

-

-

-

-

Total

188.63

191.26

190.63

193.64

188.35

Uses of funds

Fixed assets

Gross block

25.62

25.02

24.52

24.90

23.08

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

14.42

12.62

10.42

12.28

10.12

Net block

11.20

12.39

14.10

12.62

12.95

Capital work-in-progress

-

1.50

1.50

1.37

1.20

Investments

99.14

100.36

93.08

93.16

92.71

Net current assets

Current assets, loans & advances

203.96

157.40

113.97

118.45

111.82

Less : current liabilities & provisions

125.67

80.40

32.02

31.96

30.33

Total net current assets

78.29

77.00

81.95

86.49

81.49

Miscellaneous expenses not written

-

-

-

-

-

Total

188.63

191.26

190.63

193.64

188.35

Notes:

Book value of unquoted investments

99.14

100.36

93.08

93.16

92.71

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

37.95

36.38

41.26

33.59

24.74

Number of equity sharesoutstanding (Lacs)

307.86

307.86

307.86

307.86

307.86